Cargando…

Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway

BACKGROUND: Thrombolytic therapy with tissue plasminogen activator (tPA) benefits patients with acute ischemic stroke. However, tPA increases the risk for intracerebral bleeding and enhances post-ischemic neuronal injury if administered 3-4 hours after stroke. Therefore, combination therapies with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huang, Barrett, Theresa M, Zhong, Zhihui, Fernández, José A, Griffin, John H, Freeman, Robert S, Zlokovic, Berislav V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042387/
https://www.ncbi.nlm.nih.gov/pubmed/21291561
http://dx.doi.org/10.1186/1750-1326-6-13
_version_ 1782198538626662400
author Guo, Huang
Barrett, Theresa M
Zhong, Zhihui
Fernández, José A
Griffin, John H
Freeman, Robert S
Zlokovic, Berislav V
author_facet Guo, Huang
Barrett, Theresa M
Zhong, Zhihui
Fernández, José A
Griffin, John H
Freeman, Robert S
Zlokovic, Berislav V
author_sort Guo, Huang
collection PubMed
description BACKGROUND: Thrombolytic therapy with tissue plasminogen activator (tPA) benefits patients with acute ischemic stroke. However, tPA increases the risk for intracerebral bleeding and enhances post-ischemic neuronal injury if administered 3-4 hours after stroke. Therefore, combination therapies with tPA and neuroprotective agents have been considered to increase tPA's therapeutic window and reduce toxicity. The anticoagulant factor protein S (PS) protects neurons from hypoxic/ischemic injury. PS also inhibits N-methyl-D-aspartate (NMDA) excitotoxicity by phosphorylating Bad and Mdm2 which blocks the downstream steps in the intrinsic apoptotic cascade. To test whether PS can protect neurons from tPA toxicity we studied its effects on tPA/NMDA combined injury which in contrast to NMDA alone kills neurons by activating the extrinsic apoptotic pathway. Neither Bad nor Mdm2 which are PS's targets and control the intrinsic apoptotic pathway can influence the extrinsic cascade. Thus, based on published data one cannot predict whether PS can protect neurons from tPA/NMDA injury by blocking the extrinsic pathway. Neurons express all three TAM (Tyro3, Axl, Mer) receptors that can potentially interact with PS. Therefore, we studied whether PS can activate TAM receptors during a tPA/NMDA insult. RESULTS: We show that PS protects neurons from tPA/NMDA-induced apoptosis by suppressing Fas-ligand (FasL) production and FasL-dependent caspase-8 activation within the extrinsic apoptotic pathway. By transducing neurons with adenoviral vectors expressing the kinase-deficient Akt mutant Akt(K179A )and a triple FKHRL1 Akt phosphorylation site mutant (FKHRL1-TM), we show that Akt activation and Akt-mediated phosphorylation of FKHRL1, a member of the Forkhead family of transcription factors, are critical for FasL down-regulation and caspase-8 inhibition. Using cultured neurons from Tyro3, Axl and Mer mutants, we show that Tyro3, but not Axl and Mer, mediates phosphorylation of FHKRL1 that is required for PS-mediated neuronal protection after tPA/NMDA-induced injury. CONCLUSIONS: PS blocks the extrinsic apoptotic cascade through a novel mechanism mediated by Tyro3-dependent FKHRL1 phosphorylation which inhibits FasL-dependent caspase-8 activation and can control tPA-induced neurotoxicity associated with pathologic activation of NMDA receptors. The present findings should encourage future studies in animal stroke models to determine whether PS can increase the therapeutic window of tPA by reducing its post-ischemic neuronal toxicity.
format Text
id pubmed-3042387
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30423872011-02-22 Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway Guo, Huang Barrett, Theresa M Zhong, Zhihui Fernández, José A Griffin, John H Freeman, Robert S Zlokovic, Berislav V Mol Neurodegener Research Article BACKGROUND: Thrombolytic therapy with tissue plasminogen activator (tPA) benefits patients with acute ischemic stroke. However, tPA increases the risk for intracerebral bleeding and enhances post-ischemic neuronal injury if administered 3-4 hours after stroke. Therefore, combination therapies with tPA and neuroprotective agents have been considered to increase tPA's therapeutic window and reduce toxicity. The anticoagulant factor protein S (PS) protects neurons from hypoxic/ischemic injury. PS also inhibits N-methyl-D-aspartate (NMDA) excitotoxicity by phosphorylating Bad and Mdm2 which blocks the downstream steps in the intrinsic apoptotic cascade. To test whether PS can protect neurons from tPA toxicity we studied its effects on tPA/NMDA combined injury which in contrast to NMDA alone kills neurons by activating the extrinsic apoptotic pathway. Neither Bad nor Mdm2 which are PS's targets and control the intrinsic apoptotic pathway can influence the extrinsic cascade. Thus, based on published data one cannot predict whether PS can protect neurons from tPA/NMDA injury by blocking the extrinsic pathway. Neurons express all three TAM (Tyro3, Axl, Mer) receptors that can potentially interact with PS. Therefore, we studied whether PS can activate TAM receptors during a tPA/NMDA insult. RESULTS: We show that PS protects neurons from tPA/NMDA-induced apoptosis by suppressing Fas-ligand (FasL) production and FasL-dependent caspase-8 activation within the extrinsic apoptotic pathway. By transducing neurons with adenoviral vectors expressing the kinase-deficient Akt mutant Akt(K179A )and a triple FKHRL1 Akt phosphorylation site mutant (FKHRL1-TM), we show that Akt activation and Akt-mediated phosphorylation of FKHRL1, a member of the Forkhead family of transcription factors, are critical for FasL down-regulation and caspase-8 inhibition. Using cultured neurons from Tyro3, Axl and Mer mutants, we show that Tyro3, but not Axl and Mer, mediates phosphorylation of FHKRL1 that is required for PS-mediated neuronal protection after tPA/NMDA-induced injury. CONCLUSIONS: PS blocks the extrinsic apoptotic cascade through a novel mechanism mediated by Tyro3-dependent FKHRL1 phosphorylation which inhibits FasL-dependent caspase-8 activation and can control tPA-induced neurotoxicity associated with pathologic activation of NMDA receptors. The present findings should encourage future studies in animal stroke models to determine whether PS can increase the therapeutic window of tPA by reducing its post-ischemic neuronal toxicity. BioMed Central 2011-02-03 /pmc/articles/PMC3042387/ /pubmed/21291561 http://dx.doi.org/10.1186/1750-1326-6-13 Text en Copyright ©2011 Guo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Guo, Huang
Barrett, Theresa M
Zhong, Zhihui
Fernández, José A
Griffin, John H
Freeman, Robert S
Zlokovic, Berislav V
Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title_full Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title_fullStr Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title_full_unstemmed Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title_short Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
title_sort protein s blocks the extrinsic apoptotic cascade in tissue plasminogen activator/n-methyl d-aspartate-treated neurons via tyro3-akt-fkhrl1 signaling pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042387/
https://www.ncbi.nlm.nih.gov/pubmed/21291561
http://dx.doi.org/10.1186/1750-1326-6-13
work_keys_str_mv AT guohuang proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT barretttheresam proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT zhongzhihui proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT fernandezjosea proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT griffinjohnh proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT freemanroberts proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway
AT zlokovicberislavv proteinsblockstheextrinsicapoptoticcascadeintissueplasminogenactivatornmethyldaspartatetreatedneuronsviatyro3aktfkhrl1signalingpathway